Randomized, Multicenter Study Comparing Expanded Polytetrafluoroethylene-covered Endoprosthesis Placement with Percutaneous Transluminal Angioplasty in the Treatment of Superficial Femoral Artery Occlusive Disease

Journal of Vascular and Interventional Radiology

Volumn 19, Issue 6, 2008, Pages 823-832

  Saxon, Richard R ^a   Dake, Michael D ^b   Volgelzang, Robert L ^c   Katzen, Barry T ^d   Becker, Gary J ^e  

^a Tri City Medical Center   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c NORTHWESTERN MEMORIAL HOSPITAL   (United States)

^d BAPTIST CARDIAC AND VASCULAR INSTITUTE   (United States)

^e UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTERY OCCLUSION; ARTERY PROSTHESIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ECHOGRAPHY; FEMALE; FEMORAL ARTERY; HUMAN; INTERMETHOD COMPARISON; INTERVENTIONAL RADIOLOGY; LIMB ISCHEMIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VASCULAR PATENCY;

ADULT; AGED; AGED, 80 AND OVER; ALLOYS; ANGIOPLASTY, BALLOON; ARTERIAL OCCLUSIVE DISEASES; BLOOD VESSEL PROSTHESIS; COATED MATERIALS, BIOCOMPATIBLE; FEMALE; FEMORAL ARTERY; HUMANS; MALE; MIDDLE AGED; POLYTETRAFLUOROETHYLENE; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; STENTS; TREATMENT OUTCOME; VASCULAR PATENCY;

EID: 44049095732     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvir.2008.02.008     Document Type: Article

References (45)

1. Rutherford R.B., Baker J.D., Ernst C., et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg 26 (1997) 517-538
2. BASIL trial participants. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicenter, randomised controlled trial. Lancet 366 (2005) 1925-1934
3. Becker G.J., Katzen B.T., and Dake M.D. Noncoronary angioplasty. Radiology 170 (1989) 921-940
4. Lammer J. Femoropopliteal artery obstructions: from the balloon to the stent-graft. Cardiovasc Intervent Radiol 24 (2001) 73-83
5. TASC. Management of peripheral arterial disease (PAD): TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg 31 (2000) S1-S296
6. Currie I.C., Wakeley C.J., Cole S.E., et al. Femoropopliteal angioplasty for severe limb ischemia. Br J Surg 81 (1994) 191-193
7. Löfberg A.M., Karacagil S., Ljungman C., et al. Percutaneous transluminal angioplasty of the femoropopliteal arteries in limbs with chronic critical lower limb ischemia. J Vasc Surg 34 (2001) 114-121
8. Black III J.H., LaMuraglia G.M., Kwolek C.J., Brewster D.C., Watkins M.T., and Cambria R.P. Contemporary results of angioplasty-based infrainguinal percutaneous interventions. J Vasc Surg 42 (2005) 932-939
9. Kudo T., Chandra F.A., and Ahn S.S. The effectiveness of percutaneous transluminal angioplasty for the treatment of critical limb ischemia: a 10-year experience. J Vasc Surg 41 (2005) 423-435
10. Capek P., McLean G.K., and Berkowitz H.D. Femoropopliteal angioplasty: factors influencing long-term success. Circulation 83 (1991) I70-I80
11. Jämsén T.S., Manninen H.I., Jaakkola P.A., and Matsi P.J. Long-term outcome of patients with claudication after balloon angioplasty of the femoropopliteal arteries. Radiology 225 (2002) 345-352
12. Muradin G.S., Bosch J.C., Stijnen T., and Hunink M.G. Balloon dilation and stent implantation for treatment of femoropopliteal arterial disease: meta-analysis. Radiology 221 (2001) 137-145
13. Cejna M., Thurnher S., Illiasch H., et al. PTA versus Palmaz stent placement in femoropopliteal artery obstructions: a multicenter prospective randomized study. J Vasc Interv Radiol 12 (2001) 23-31
14. Ahmadi R., Schillinger M., Maca T., and Minar E. Femoropopliteal arteries: immediate and long-term results with a Dacron-covered stent-graft. Radiology 223 (2002) 345-350
15. Henry M., Amor M., Cragg A., et al. Occlusive and aneurysmal peripheral arterial disease: assessment of a stent-graft system. Radiology 201 (1996) 717-724
16. Lammer J., Dake M.D., Bleyn J., et al. Peripheral arterial obstruction: prospective study of treatment with a transluminally placed self-expanding stent-graft. International Trial Study Group. Radiology 217 (2000) 95-101
17. Cragg A.H., and Dake M.D. First report of percutaneous fem/pop endo graft. Radiology 187 (1993) 643-648
18. Bauermeister G. Endovascular stent-grafting in the treatment of superficial femoral artery occlusive disease. J Endovasc Ther 8 (2001) 315-320
19. Hartung O., Otero A., Dubuc M., et al. Efficacy of Hemobahn in the treatment of superficial femoral artery lesions in patients with acute or critical ischemia: a comparative study with claudicants. Eur J Vasc Endovasc Surg 30 (2005) 300-306
20. Railo M., Roth W.D., Edgren J., et al. Preliminary results with endoluminal femoropopliteal thrupass. Ann Chir Gynaecol 90 (2001) 15-18
21. Jahnke T., Andresen R., Müller-Hülsbeck S., et al. Hemobahn stent-grafts for treatment of femoropopliteal arterial obstructions: midterm results of a prospective trial. J Vasc Interv Radiol 14 (2003) 41-51
22. Bray P.J., Robson W.J., and Bray A.E. Percutaneous treatment of long superficial femoral artery occlusive disease: efficacy of the Hemobahn stent-graft. J Endovasc Ther 10 (2003) 619-628
23. Daenens K., Maleux G., Fourneau I., and Nevelsteen A. Hemobahn stent-grafts in the treatment of femoropopliteal occlusive disease. J Cardiovasc Surg (Torino) 46 (2005) 25-29
24. Saxon R.R., Coffman J.M., Gooding J.M., Natuzzi E., and Ponec D.J. Long-term results of ePTFE stent-graft versus angioplasty in the femoropopliteal artery: single center experience from a prospective, randomized trial. J Vasc Interv Radiol 14 (2003) 303-311
25. Saxon R.R., Coffman J.M., Gooding J.M., and Ponec D.J. Endograft use in the femoral and popliteal arteries. Tech Vasc Interv Radiol 7 (2004) 6-15
26. Rutherford R.B., and Becker G.J. Standards for evaluating and reporting the results of surgical and percutaneous therapy for peripheral arterial disease. J Vasc Intervent Radiol 2 (1991) 169-174
27. Sacks D., Marinelli D.L., Martin L.G., Spies J.B., and Society of Interventional Radiology Technology Assessment Committee. Reporting standards for clinical evaluation of new peripheral arterial revascularization devices. Radiology 14 (2003) S395-S404
28. Vroegindeweij D., Tielbeek A.V., Buth J., van Kints M.J., Landman G.H., and Mali W.P. Recanalization of femoropopliteal occlusive lesions: a comparison of long-term clinical, color duplex US, and arteriographic follow-up. J Vasc Interv Radiol 6 (1995) 331-337
29. Machan L. Drug eluting stents in the infrainguinal circulation. Techn Vasc Interv Radiol 7 (2004) 28-32
30. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 45 suppl A (2007) S5A-S67A
31. Bleyn J. Ten-year follow-up of Hemobahn in SFA occlusions. Presented at Internation Congress XX on Endovascular Interventions, Scottsdale, Arizona, February 9-15, 2007. J Endovasc Therapy, 1007 Feb, 14 Suppl 1, I1-I35, Abstracts from the International Congress XX on Endovascular Interventions.
32. Kedora J., Hohmann S., Garrett W., Munschaur C., Theune B., and Gable D. Randomized comparison of percutaneous Viabahn Stent-Grafts versus prosthetic femoral-popliteal bypass in the treatment of superficial femoral arterial occlusive disease. J Vasc Surg 45 1 (2007) 10-16
33. Fischer M., Schwabe C., and Schulte K.L. Value of the Hemobahn/Viabahn endoprosthesis in the treatment of long chronic lesions of the superficial femoral artery: 6 years of experience. J Endovasc Ther 13 (2006) 281-290
34. Saxon R., Coffman J., Gooding J., and Ponce D.J. Long-term patency and clinical outcome of the Viabahn stent-graft for femoropopliteal artery obstructions. J Vasc Interv Radiol 18 (2007) 1341-1350
35. Veith F.J., Gupta S.K., Ascer E., et al. Six-year prospective multicenter randomized comparison of autologous saphenous vein and expanded polytetrafluoroethylene grafts in infrainguinal arterial reconstructions. J Vasc Surg 3 (1986) 104-114
36. Johnson W.C., and Lee K.K. A comparative evaluation of polytetrafluoroethylene, umbilical vein, and saphenous vein bypass grafts for femoral-popliteal above-knee revascularization: a prospective randomized Department of Veterans Affairs cooperative study. J Vasc Surg 32 (2000) 268-277
37. Burger D.H., Kappetein A.P., van Bockel J.H., and Breslau P.J. A prospective randomized trial comparing vein with polytetrafluoroethylene in above-knee femoropopliteal bypass grafting. J Vasc Surg 32 (2000) 278-283
38. Green R.M., Abbott W.M., Matsumoto T., et al. Prosthetic above-knee femoropopliteal bypass grafting: five-year results of a randomized trial. J Vasc Surg 31 (2000) 417-425
39. Conrad M.F., Cambria R.P., Stone H.D., et al. Intermediate results of percutaneous endovascular therapy of femoropopliteal occlusive disease: a contemporary series. J Vasc Surg 44 (2006) 762-769
40. Duda S.H., Bosiers M., Lammer J., et al. Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO II trial. J Vasc Interv Radiol 16 (2005) 331-338
41. Schillinger M., Sabeti S., Loewe C., et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med 354 (2006) 1879-1888
42. Schillinger M., Sabeti S., Dick P., et al. Sustained benefit at 2 years of primary femoropopliteal stenting compared with ballon angioplasty with optional stenting. Circulation 115 (2007) 2745-2749
43. Gray B.H., Sullivan T.M., Childs M.B., et al. High incidence of restenosis/reocclusion of stents in the percutaneous treatment of long-sement superficial femoral artery disease after suboptimal angioplasty. J Vasc Surg 25 (1997) 74-83
44. Scheinert D., Scheinert S., Sax J., et al. Prevalence and clinical impact of stent fractures after femoropopliteal stenting. J Am Coll Cardiol 45 (2005) 312-315
45. Schlager O., Dick P., Sabeti S., et al. Long-segment SFA stenting: the dark sides-in-stent restenosis, clinical deterioration, and stent fractures. J Endovasc Ther 12 (2005) 676-684